Date | Time | Source | Announcement |
---|---|---|---|
15 Jan 2010 | 07:00 AM | Holding(s) in Company | |
12 Nov 2009 | 07:00 AM | Successful Outcome of Phase 1 | |
11 Nov 2009 | 01:24 PM | Result of AGM | |
09 Nov 2009 | 07:00 AM | activity of interferon beta a | |
26 Oct 2009 | 07:00 AM | Notice of Investor Conference | |
14 Oct 2009 | 02:35 PM | Notice of Annual Report and A | |
08 Sep 2009 | 11:25 AM | Grant of Options | |
04 Sep 2009 | 07:00 AM | Directorate Changes | |
04 Sep 2009 | 07:00 AM | US Patent Granted | |
04 Sep 2009 | 07:00 AM | Final Results | |
02 Sep 2009 | 07:00 AM | Notice of Results | |
17 Jul 2009 | 03:00 PM | Holding(s) in Company | |
30 Jun 2009 | 09:56 AM | Total Voting Rights | |
25 Jun 2009 | 02:36 PM | Holding(s) in Company | |
23 Jun 2009 | 07:00 AM | Holding(s) in Company | |
15 Jun 2009 | 11:06 AM | Second Closing of the Fundrai | |
12 Jun 2009 | 11:22 AM | Result of General Meeting | |
27 May 2009 | 07:00 AM | Fundraising Announcement | |
01 Apr 2009 | 07:00 AM | Preliminary biomarker data | |
31 Mar 2009 | 07:00 AM | Change of Adviser | |
26 Mar 2009 | 07:00 AM | Half Yearly Results | |
24 Mar 2009 | 11:14 AM | Notice of Results | |
17 Mar 2009 | 07:00 AM | Progress update: Clinical Tri | |
13 Nov 2008 | 12:15 PM | Result of AGM | |
07 Nov 2008 | 03:25 PM | Change of NOMAD | |
31 Oct 2008 | 09:00 AM | Total Voting Rights | |
20 Oct 2008 | 07:00 AM | Director/PDMR Shareholding an | |
10 Oct 2008 | 01:53 PM | Posting of 2008 Annual Report | |
08 Oct 2008 | 09:12 AM | Change of Adviser Name | |
22 Sep 2008 | 07:00 AM | Research Update | |
04 Aug 2008 | 10:00 AM | Director/PDMR Shareholding | |
31 Jul 2008 | 07:00 AM | Final Results | |
29 Jul 2008 | 07:00 AM | Commencement of Clinical Tria | |
14 Jul 2008 | 11:48 AM | Notice of Results | |
23 May 2008 | 07:00 AM | Presentation of data at ATS | |
13 Mar 2008 | 07:01 AM | Director Shareholding | |
12 Mar 2008 | 07:01 AM | Interim Results | |
25 Feb 2008 | 07:01 AM | Notice of Results | |
11 Feb 2008 | 07:01 AM | Patent Granted | |
12 Dec 2007 | 07:01 AM | Research Collaboration | |
15 Nov 2007 | 07:01 AM | Result of AGM | |
12 Nov 2007 | 08:25 AM | Contract with Alpha Biologics | |
31 Oct 2007 | 12:45 PM | Director/PDMR Shareholding | |
28 Sep 2007 | 07:04 AM | Licence/ Supply by Rentschler | |
26 Sep 2007 | 07:01 AM | Final Results | |
20 Aug 2007 | 07:00 AM | Notice of Preliminary Results | |
17 Aug 2007 | 01:52 PM | AIM Rule 26 | |
16 Aug 2007 | 02:54 PM | Change of Adviser | |
28 Jun 2007 | 02:30 PM | Director/PDMR Shareholding | |
12 Jun 2007 | 07:01 AM | Research Update |
Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.
Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.
Synairgen share price launched at 155p in 2004.